Comparative Study on the Release Rate of Rabeprazole Sodium Enteric-coated Tablets

Bioequivalence of Raberazole enteric-coated tablets in healthy volunteers;

The Clinical Observation of Rabeprazole Sodium in Peptic Ulcer Treatment;

The formation and crystallization of rabeprazole sodium;

HPLC determination of rabeprazole sodium for injection and its related substances

Objective To evaluate the effect and safety of Rabeprazole at the dose of 10 mg per day on peptic ulcer, comparing with omeprazole at the dose of 20 mg per day.

Rabeprazole is second-generation product of proton pump inhibitors (PPIs) after the producing of Omeprazole and Lanprazole.

Studies on the bioequivalence of two sodium rebeprazole entric tablets in healthy volunteers;